julie kim - Search News

Takeda Pharmaceutical Names U.S. Head Julie Kim

The Wall Street Journal on MSN · 2d

Takeda Pharmaceutical Names U.S. Head Julie Kim as Next CEO

The Japanese drugmaker said that Kim, president of its U.S. business unit, will succeed Chief Executive Christophe Weber, who plans to retire in June next year.

Business Insider · 2d

Takeda CEO Christophe Weber to retire in 2026, Julie Kim to succeed

Takeda (TAK) announced that its board of directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S.

Hosted on MSN · 2d

Japan's Takeda says CEO Weber to step down, raises profit forecast

Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after 12 years in management at Japan's biggest drugmaker. Julie Kim, president of the company's U.S. unit, was named to succeed Weber in June.

1d

Takeda picks first woman as CEO of centuries-old drugmaker

Julie Kim has been running Takeda’s US operations since 2022 and will assume the role of CEO in June next year, subject to shareholder approval.

Takeda Drops Epilepsy Drug, Names New CEO Amid Q3 Earnings

Analysts were unfazed by the news that Takeda will cease development of soticlestat after Phase III failures, while ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results